QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,331 signal articles · 531 in last 24h · 104,428 total before filter · latest 57m ago
531last 24h
2513last 7d
479● bullish (7d)
255● bearish (7d)
198publishers
AllMacro203Earnings1519M&A141Regulatory16Product7Analyst29
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Diamondback Energy Q2 Earnings Call Highlights
MarketBeat1d agoneutral
Diamondback Energy Q2 Earnings Call Highlights

Diamondback Energy (NASDAQ:FANG) said its second-quarter operational performance and view of global oil inventories support a potential path toward low-single-digit organic production growth in 2027, while management emphasized it intends to retain flexibility amid commodity-market volatility. Chie

Cipher Mining Q2 Earnings Call Highlights
MarketBeat1d agoneutral
Cipher Mining Q2 Earnings Call Highlights

Cipher Mining (NASDAQ:CIFR) said its second-quarter 2026 business update reflected continued progress in its transition toward developing and operating data centers for high-performance computing, or HPC, customers. The company highlighted an accelerated delivery at its Black Pearl campus, an $810 m

Bruker Q2 Earnings Call Highlights
MarketBeat1d agoneutral
Bruker Q2 Earnings Call Highlights

Bruker (NASDAQ:BRKR) reported second-quarter revenue growth and expanded profitability as demand improved for scientific instruments, particularly in biopharma and several “deep tech” markets including semiconductor metrology, security detection and energy research. Second-quarter reported revenue

Pfizer raises revenue outlook after quarterly earnings top estimates
Proactive1d agoneutral
Pfizer raises revenue outlook after quarterly earnings top estimates

Pfizer Inc (NYSE:PFE, XETRA:PFE) beat Wall Street expectations for its second-quarter 2026 results and raised the midpoint of its full-year revenue guidance, as growth from launched and acquired products helped offset declines in its COVID-19 portfolio. The pharmaceutical company reported...

BioNTech Q2 Earnings Call Highlights
MarketBeat1d agoneutral
BioNTech Q2 Earnings Call Highlights

BioNTech (NASDAQ:BNTX) reported second-quarter 2026 revenue of €106 million, down from €261 million a year earlier, as lower U.S. demand for its COVID-19 vaccine weighed on results. The prior-year quarter also benefited from a one-time compensation payment from Pfizer related to its decision to opt